J. King

Most-cited papers

1. Real world experience of trastuzumab deruxtecan for the treatment of metastatic breast cancer in the UK.

   A. Cheng, S. Frank, K. Baines, M. Nathan +16 more

   2024Journal of Clinical Oncology4 citations

   Semantic Scholar

   Save

2. A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer.

   A. Lerner, K. Keshwani, A. Okines, B. Sanderson +15 more

   2022Clinics in oncology4 citations

   Semantic Scholar

   Save

3. Abemaciclib in combination with endocrine therapy for the treatment of HR-positive/HER2-negative locally advanced/metastatic breast cancer in the UK: an observational study

   J. King, W. Fakhouri, R. Jarvis, Waleed Badreldin +3 more

   2025BMC Cancer1 citations Open access

   Semantic Scholar

   Save

4. Readiness for adjuvant ribociclib – results of a local audit and national survey

   E. Gimson, J. Richman, Neha Chopra, A. Sheri +2 more

   2026Clinics in oncology0 citations

   Semantic Scholar

   Save

5. Fulvestrant in hormone receptor-positive advanced breast cancer: A UK retrospective multicenter study.

   K. Keshwani, A. Lerner, B. Sanderson, R. Board +14 more

   2019Journal of Clinical Oncology0 citations

   Semantic Scholar

   Save